人多能干细胞衍生工程化组织：临床考量。
Human Pluripotent Stem Cell-Derived Engineered Tissues: Clinical Considerations.
机构信息
Department of Bioengineering, University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington, Seattle, WA, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA; Center for Cardiovascular Biology, University of Washington, Seattle, WA, USA.
Department of Bioengineering, University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington, Seattle, WA, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA; Center for Cardiovascular Biology, University of Washington, Seattle, WA, USA; Department of Medicine/Cardiology, University of Washington, Seattle, WA, USA.
出版信息
Cell Stem Cell. 2018 Mar 1;22(3):294-297. doi: 10.1016/j.stem.2018.01.015.
Abstract
The combined power of human pluripotent stem cells and tissue engineering promises to revolutionize medicine by building tissue patches and artificial replacement organs for patients battling diverse diseases. Here, we articulate some big questions that need to be addressed before such engineered tissues become mainstream in the clinic.
摘要
人类多能干细胞与组织工程的联合力量有望通过为患有各种疾病的患者构建组织贴片和人工替代器官来彻底改变医学。在这里，我们阐述了一些在这些工程组织成为临床主流之前需要解决的重大问题。
相似文献
1
Human Pluripotent Stem Cell-Derived Engineered Tissues: Clinical Considerations.人多能干细胞衍生工程化组织：临床考量。
Cell Stem Cell. 2018 Mar 1;22(3):294-297. doi: 10.1016/j.stem.2018.01.015.
2
[3D revolution of stem cells: building a retina in vitro].[干细胞的3D革命：体外构建视网膜]
Med Sci (Paris). 2011 Aug-Sep;27(8-9):709-12. doi: 10.1051/medsci/2011278012. Epub 2011 Aug 31.
3
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.在人类工程心脏组织中使源自人多能干细胞的心肌细胞成熟。
Adv Drug Deliv Rev. 2016 Jan 15;96:110-34. doi: 10.1016/j.addr.2015.04.019. Epub 2015 May 5.
4
Direct hydrogel encapsulation of pluripotent stem cells enables ontomimetic differentiation and growth of engineered human heart tissues.多能干细胞的直接水凝胶封装能够实现工程化人类心脏组织的仿生分化和生长。
Biomaterials. 2016 Mar;83:383-95. doi: 10.1016/j.biomaterials.2015.12.011. Epub 2015 Dec 18.
5
Prospects for stem cell-based therapy.基于干细胞的治疗前景。
Cell. 2008 Feb 22;132(4):544-8. doi: 10.1016/j.cell.2008.02.009.
6
Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application.基于人类干细胞的生物工程心脏组织用于临床应用。
Adv Biochem Eng Biotechnol. 2018;163:117-146. doi: 10.1007/10_2017_24.
7
Deriving, regenerating, and engineering CNS tissues using human pluripotent stem cells.利用人类多能干细胞衍生、再生和构建中枢神经系统组织。
Curr Opin Biotechnol. 2017 Oct;47:36-42. doi: 10.1016/j.copbio.2017.05.010. Epub 2017 Jun 9.
8
Engineering human cells and tissues through pluripotent stem cells.通过多能干细胞对人类细胞和组织进行工程化改造。
Curr Opin Biotechnol. 2016 Aug;40:133-138. doi: 10.1016/j.copbio.2016.03.010. Epub 2016 Apr 12.
9
Towards organogenesis and morphogenesis in vitro: harnessing engineered microenvironment and autonomous behaviors of pluripotent stem cells.迈向体外器官发生和形态发生：利用工程化微环境和多能干细胞的自主行为
Integr Biol (Camb). 2018 Oct 15;10(10):574-586. doi: 10.1039/c8ib00116b.
10
Regenerative medicine for urological tissues: Updated review 2018.泌尿组织再生医学：2018年最新综述
Int J Urol. 2018 Sep;25(9):788-791. doi: 10.1111/iju.13762. Epub 2018 Jul 31.
引用本文的文献
1
Supramolecular Additive Screening to Engineer Microfibrous Rafts for Expansion of Pluripotent Stem Cells in Dynamic Suspension.用于构建微纤维筏以在动态悬浮中扩增多能干细胞的超分子添加剂筛选
Adv Healthc Mater. 2025 Apr;14(11):e2404186. doi: 10.1002/adhm.202404186. Epub 2025 Mar 10.
2
Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells.诱导多能干细胞的心脏再生治疗的现状。
Int J Mol Sci. 2024 May 26;25(11):5772. doi: 10.3390/ijms25115772.
3
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.诱导多能干细胞（iPSCs）：诱导的分子机制与应用。
Signal Transduct Target Ther. 2024 Apr 26;9(1):112. doi: 10.1038/s41392-024-01809-0.
4
The challenges and prospects of smooth muscle tissue engineering.平滑肌组织工程面临的挑战与展望。
Regen Med. 2024 Mar;19(3):135-143. doi: 10.2217/rme-2023-0230. Epub 2024 Mar 5.
5
Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium.BRAF-V600E 对工程心肌细胞周期、代谢和功能的时变效应。
Sci Adv. 2024 Jan 26;10(4):eadh2598. doi: 10.1126/sciadv.adh2598. Epub 2024 Jan 24.
6
Immature human engineered heart tissues engraft in a guinea pig chronic injury model.不成熟的人源工程心脏组织在豚鼠慢性损伤模型中移植。
Dis Model Mech. 2023 May 1;16(5). doi: 10.1242/dmm.049834. Epub 2023 Jun 5.
7
Leaf-venation-directed cellular alignment for macroscale cardiac constructs with tissue-like functionalities.叶脉导向的宏观心脏构建体的细胞取向以实现类似组织的功能。
Nat Commun. 2023 Apr 12;14(1):2077. doi: 10.1038/s41467-023-37716-1.
8
Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?多能干细胞衍生心肌细胞的心脏细胞治疗：已经完成了什么，还有什么需要做？
Curr Cardiol Rep. 2022 May;24(5):445-461. doi: 10.1007/s11886-022-01666-9. Epub 2022 Mar 11.
9
Process control and modeling strategies for enabling high density culture of human pluripotent stem cells in stirred tank bioreactors.在搅拌罐生物反应器中实现人类多能干细胞高密度培养的过程控制和建模策略。
STAR Protoc. 2021 Dec 9;2(4):100988. doi: 10.1016/j.xpro.2021.100988. eCollection 2021 Dec 17.
10
Process parameter development for the scaled generation of stem cell-derived pancreatic endocrine cells.规模化生成干细胞来源的胰腺内分泌细胞的工艺参数开发。
Stem Cells Transl Med. 2021 Nov;10(11):1459-1469. doi: 10.1002/sctm.21-0161. Epub 2021 Aug 13.
本文引用的文献
1
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease.在慢性肝病小鼠模型中工程化人肝组织的原位扩增
Sci Transl Med. 2017 Jul 19;9(399). doi: 10.1126/scitranslmed.aah5505.
2
The hope and the hype of organoid research.类器官研究的希望与炒作。
Development. 2017 Mar 15;144(6):938-941. doi: 10.1242/dev.150201.
3
Distilling complexity to advance cardiac tissue engineering.提炼复杂性以推进心脏组织工程学。
Sci Transl Med. 2016 Jun 8;8(342):342ps13. doi: 10.1126/scitranslmed.aad2304.
4
Co-ordinated ocular development from human iPS cells and recovery of corneal function.人类诱导多能干细胞协调的眼部发育和角膜功能的恢复。
Nature. 2016 Mar 17;531(7594):376-80. doi: 10.1038/nature17000. Epub 2016 Mar 9.
5
Pluripotent stem cells progressing to the clinic.多能干细胞向临床应用推进。
Nat Rev Mol Cell Biol. 2016 Mar;17(3):194-200. doi: 10.1038/nrm.2016.10.
6
The advancement of human pluripotent stem cell-derived therapies into the clinic.人类多能干细胞衍生疗法向临床的推进。
Development. 2015 Oct 15;142(20):3614. doi: 10.1242/dev.131250.
7
The winding road to regenerating the human heart.通往人类心脏再生的曲折之路。
Cardiovasc Pathol. 2015 May-Jun;24(3):133-40. doi: 10.1016/j.carpath.2015.02.004. Epub 2015 Feb 19.
8
Manufacturing road map for tissue engineering and regenerative medicine technologies.组织工程与再生医学技术的制造路线图。
Stem Cells Transl Med. 2015 Feb;4(2):130-5. doi: 10.5966/sctm.2014-0254. Epub 2015 Jan 9.
9
Vascularized and functional human liver from an iPSC-derived organ bud transplant.源自 iPSC 衍生类器官芽移植的血管化和功能性人肝。
Nature. 2013 Jul 25;499(7459):481-4. doi: 10.1038/nature12271. Epub 2013 Jul 3.
10
Engineering complex tissues.工程复杂组织。
Sci Transl Med. 2012 Nov 14;4(160):160rv12. doi: 10.1126/scitranslmed.3004890.
Zotero 插件